Welcome Back
Click “Sign in” to agree to Cointime’s Terms of Service and acknowledge that Cointime’s Privacy Policy applies to you.
Join CoinTime
Already have an account?
Click “page.Sign up” to agree to Cointime’s <a class="underline" href="#term-of-service">Terms of Service</a> and acknowledge that Cointime’s a class="underline" href="#privacy-policy">Privacy Policy</a> applies to you.
Sign in with email
Sign up with email
Your email
Check your inbox
Click the link we sent to to sign in.
Click the link we sent to to sign up.
Huisheng Biopharmaceutical
company
About
Huisheng Bio is a diabetes and complication treatment solution provider.
- 51 - 100
Details
- Last Funding Type
- Series A
- Last Funding Money Raised
- ¥500M
- Industries
- Biopharma,Biotechnology,Health Care,Medical,Pharmaceutical
- Founded date
- Jan 1, 2019
- Number Of Employee
- 51 - 100
- Operating Status
- Active
Huisheng Bio is a diabetes and complication treatment solution provider. The company was founded in 2019 and is headquartered in Jilin, China.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
¥500M
Huisheng Biopharmaceutical has raised a total of
¥500M
in funding over 2 rounds. Their latest funding was raised on
Jun 1, 2022 from a Series A round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Jun 1, 2022 | Series A | ¥500M | 1 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
—
1
Huisheng Biopharmaceutical is funded by 1 investors.
Chinalife Tech-Innovation Fund
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
Chinalife Tech-Innovation Fund
|
— | Series A |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
